2041 Georgia Ave NW, Washington, DC, 20060 · (202) 745-6100
Beds
192
FY 2025
Star rating
1 of 5
Patient survey: 2 of 5
Net patient revenue
$273.8M
FY 2025
Net income
-$10.8M
Patient care margin -16.6%
Discharges
6,337
Occupancy 58.8%
Clinicians
232
From the hospital's yearly cost reports (fiscal years as the hospital reports them)
Locations are shown at the center of the ZIP code.
US dollars as reported. Patient care margin = net patient revenue minus operating expenses, before other income such as grants, donations and investments.
| Fiscal year | Net patient revenue | Operating expenses | Patient care margin | Net income | Discharges | Uncompensated care | Medicare days | Medicaid days |
|---|---|---|---|---|---|---|---|---|
| 2025 | $273.8M | $319.2M | -16.6% | -$10.8M | 6,337 | $20.9M | 19.7% | 12.6% |
Official hospital quality measures with the national median across hospitals. For ratios, 1.00 means as many cases as expected.
| Death rate for COPD patients | 7% | US median 8.5% |
| Death rate for heart attack patients | 10.9% | US median 11.8% |
| Death rate for heart failure patients | 9.9% | US median 11% |
| Hospital-wide death rate within 30 days | 4.3% | US median 3.9% |
| Death rate for pneumonia patients | 16.8% | US median 15.2% |
| Death rate for stroke patients | 9.6% | US median 11.6% |
Medicare clinicians who list this hospital, by specialty
Inpatient stays by diagnosis related group (DRG), 2024
Official US government data: hospital records, ownership records, yearly cost reports and quality measures, linked by the hospital's CCN and NPI. Financials are for fiscal years as reported by the hospital.
Medicare clinicians who work here
| 2023 | $294.6M | $319.5M | -8.4% | $16.3M | 7,068 | $16.4M | 22.6% | 12.2% |
| 2022 | $292.4M | $339.1M | -16.0% | $24.0M | 7,412 | $4.5M | 25.6% | 11.4% |
| 2021 | $280.4M | $326.2M | -16.3% | $47.0M | 7,320 | $11.5M | 23.3% | 20.6% |
| 2020 | $267.1M | $300.1M | -12.4% | $9.8M | 7,552 | $7.1M | 22.9% | 29.4% |
| Readmission rate for COPD | 20.2% | US median 19.8% |
| Readmission rate after a heart attack | 14.3% | US median 14.4% |
| Readmission rate for heart failure | 22.6% | US median 21.3% |
| Readmission rate for pneumonia | 19.2% | US median 17.2% |
| Serious complications (patient safety composite) | 1.62 | US median 0.96 · worse |
| C. diff intestinal infections (ratio to expected) | 0.62 | US median 0.28 |
| Central line bloodstream infections (ratio to expected) | 0.88 | US median 0.48 |
| MRSA bloodstream infections (ratio to expected) | 0.63 | US median 0.60 |
| Catheter urinary tract infections (ratio to expected) | 0.20 | US median 0.40 · better |
| Doctors always communicated well | 73% | US median 79% |
| Nurses always communicated well | 64% | US median 80% |
| Patient survey summary star rating | 2 of 5 | US median 3 of 5 |
| Area around the room always quiet at night | 54% | US median 59% |
| Patients who rated the hospital 9 or 10 out of 10 | 51% | US median 72% |
| Room and bathroom always clean | 64% | US median 73% |
| Patients who would definitely recommend the hospital | 51% | US median 71% |
| Patients who left the emergency department before being seen | 2% | US median 1% |
| Median time in the emergency department before leaving (minutes) | 222 min | US median 148 min |
| Patients prescribed 2 or more opioids or opioids with benzodiazepines at discharge | 5% | US median 15% |
| Patients who got appropriate care for severe sepsis and septic shock | 70% | US median 65% |
| Healthcare workers given the flu vaccine | 95% | US median 79% |
| 24 |
| $26,061.17 |
| $8,667.25 |
| $5,985.69 |
| DRG 682 RENAL FAILURE WITH MCC | 24 | $58,585.88 | $16,657.29 | $11,457.18 |
| DRG 885 PSYCHOSES | 22 | $31,032.32 | $15,752.23 | $11,869.17 |
| DRG 812 RED BLOOD CELL DISORDERS WITHOUT MCC | 21 | $32,307.62 | $10,160.29 | $7,177.67 |
| DRG 870 SEPTICEMIA OR SEVERE SEPSIS WITH MV >96 HOURS | 20 | $293,325.05 | $77,491.60 | $58,777.93 |
| DRG 641 MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM, FLUIDS AND ELECTROLYTES WITHOUT MCC | 20 | $35,693.15 | $8,593.30 | $5,829.71 |
| DRG 853 INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURES WITH MCC | 20 | $183,048.80 | $57,856.05 | $40,556.82 |
| DRG 280 ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH MCC | 19 | $86,346.16 | $20,906.68 | $12,400.10 |
| DRG 378 GASTROINTESTINAL HEMORRHAGE WITH CC | 19 | $40,561.53 | $10,844.58 | $7,294.77 |
| DRG 683 RENAL FAILURE WITH CC | 19 | $33,117.53 | $10,244.79 | $6,629.69 |
| DRG 872 SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MCC | 17 | $37,888.94 | $11,841.29 | $7,681.44 |
| DRG 640 MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM, FLUIDS AND ELECTROLYTES WITH MCC | 17 | $37,164.65 | $15,741.53 | $10,642.23 |
| DRG 190 CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH MCC | 17 | $73,757.24 | $12,725.53 | $8,466.56 |
Hospital outpatient services by payment group (APC), 2024
| Service group | Services | Patients | Medicare pays per service | All hospitals |
|---|---|---|---|---|
| APC 5491 Level 1 Intraocular Procedures | 173 | 143 | $1,872.92 | $1,751.67 |
| APC 8011 Comprehensive Observation Services | 43 | 42 | $2,227.00 | $2,090.36 |
| APC 5374 Level 4 Urology and Related Services | 21 | 19 | $2,706.60 | $2,629.24 |
| APC 5373 Level 3 Urology and Related Services | 19 | 16 | $1,573.02 | $1,516.28 |
| APC 5191 Level 1 Endovascular Procedures | 18 | 18 | $2,387.28 | $2,207.96 |
| APC 5072 Level 2 Excision/ Biopsy/ Incision and Drainage | 16 | 16 | $1,298.17 | $1,219.56 |
| APC 5492 Level 2 Intraocular Procedures | 13 | 11 | $3,068.95 | $3,116.50 |
| APC 5183 Level 3 Vascular Procedures | 12 | - | $2,598.44 | $2,405.01 |
| APC 5112 Level 2 Musculoskeletal Procedures | 11 | 11 | $1,310.20 | $1,196.16 |
| APC 5415 Level 5 Gynecologic Procedures | - | - | - | $3,792.42 |
| APC 5184 Level 4 Vascular Procedures | - | - | - | $3,945.82 |
| APC 5073 Level 3 Excision/ Biopsy/ Incision and Drainage | - | - | - | $2,141.49 |
Reported payments to this teaching hospital
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 6 | $664K |
| Pfizer Inc. PFE | 2 | $64K |
| Dexcom, Inc. DXCM | 1 | $33K |
| Abbvie Inc. ABBV | 1 | $5,000 |
| Djo, LLC ENOV | 1 | $3,475 |
| Philips North America LLC PHG | 2 | $3,096 |
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $1,420 |
| Aesculap Implant Systems, LLC | 1 | $1,016 |
| Linvatec Corporation CNMD | 1 | $858 |
| Abbott Laboratories ABT | 2 | $288 |
Official US government data on Original Medicare hospital stays and outpatient services; groups with fewer than 11 cases are not published. Payments are those drug and device companies must report.
Howard University Hospital Corp is a nonprofit short-term acute care hospital in Washington, DC with 192 beds, part of Adventist Healthcare and a 1-star overall rating.
Howard University Hospital Corp in Washington, DC has 192 beds (fiscal year 2025 cost report); 479 beds are certified for Medicare. It discharged 6,337 inpatients that year, with 58.8% of its beds in use on average.
In fiscal year 2025 (ending 2025-06-30), Howard University Hospital Corp reported net patient revenue of $273.8M and operating expenses of $319.2M, a margin on patient care of -16.6%. After other income and expenses its net income was -$10.8M (-3.5% of revenue), so it lost money that year.
Howard University Hospital Corp is part of Adventist Healthcare, a health system with 5 hospitals based in Gaithersburg, MD. It is a nonprofit hospital.
Howard University Hospital Corp has an overall rating of 1 out of 5 stars in the official hospital quality ratings. Patients rate it 2 out of 5 stars in the patient survey.
No, Howard University Hospital Corp does not list emergency services.
232 Medicare clinicians list Howard University Hospital Corp as a hospital they work at, most often in Family Practice, Anesthesiology, Internal Medicine.
In 2024, Howard University Hospital Corp had 585 Medicare inpatient stays in 26 diagnosis groups. The most common was DRG 871 (septicemia or severe sepsis without mv >96 hours with mcc) with 124 stays; Medicare paid $23,757.78 per stay on average, compared with $15,524.21 across all hospitals.
In 2025, companies reported $776K in payments to Howard University Hospital Corp as a teaching hospital ($678K general and $98K for research) from 11 companies.